AI, VR, and concept cars grabbed most of the headlines at this year's CES consumer electronics show in Las Vegas, but these medical technologies on display at the event could help make a real difference in people's lives.
News & Features
Panelists at the recent J.P. Morgan Healthcare Conference in San Francisco, CA were charged with separating the hype from the reality in the field of diagnostics and offered insight into what products will win in the space.
Medtronic was one of four multinational companies chastised by Chinese regulators for referring to Taiwan as a country online.
The recently lowered U.S. corporate tax rate was a hot topic in San Francisco, CA where thousands of industry executives and investors convened for the 36th annual J.P. Morgan Healthcare Conference. We combed through dozens of company slideshows and tuned into live webcasts to find out what medtech is saying about tax reform.
FDA approved a new clinician programmer for the company's implantable pain pump, as well as a series of recent design changes aimed at improving the pump s a pain management device.
A panel of experts took a crack at the subject of artificial intelligence to help us sort out how much of a near-term impact the technology could realistically have in healthcare.
The company enrolled the first patient in a postmarket study of its Evolve workflow therapy to standardize guidance for physicians.
The website Business Insider named biomedical engineers and other positions in medtech among jobs that offer high pay and low stress. What do you think?
The transcatheter aortic valve replacement market has already seen rapid growth. But the market leaders say they've only scratched the surface in terms of the growth opportunities in the space.
Edwards Lifesciences made a strong case for choosing focus over diversification during the company's presentation at the J.P. Morgan Healthcare Conference, while several of its peers touted diversification. Which strategy seems to be working better in medtech?
The developer seeks to introduce a low-cost, point-of-care test that could deliver quick results with the help of a smartphone app.
The new GOP tax law gives companies more flexibility when it comes to capital allocation, Johnson & Johnson's CFO says. Could that lead to an uptick in mergers and acquisitions among medical device and diagnostics companies?